You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

CLINICAL TRIALS PROFILE FOR LEUPROLIDE ACETATE FOR DEPOT SUSPENSION


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00598312 ↗ Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer Completed Oakwood Laboratories, LLC Phase 3 2007-04-01 The purpose of the study is to demonstrate the safety and efficacy of Leuprolide Acetate for Injectable Suspension 22.5 mg in reducing serum testosterone to castrate levels in patients with prostate cancer.
NCT00621179 ↗ Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF Completed Colorado Center for Reproductive Medicine Phase 4 2003-03-01 This prospective randomized trial evaluates whether one can predict which infertile women with endometriosis who are candidates for in vitro fertilization will benefit from prolonged therapy with a GnRH agonist by the determination of the absence of endometrial expression of the integrin, alpha v, beta 3 vitronectin. This is a prospective randomized trial in which all patients will undergo endometrial biopsy prior to initiation of ovarian stimulation for in vitro fertilization and then undergo randomization to a three month course of a depot preparation of the GnRH agonist leuprolide acetate in depot suspension prior to ovarian stimulation or standard therapy. prio
NCT01069094 ↗ A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata Completed Repros Therapeutics Inc. Phase 1/Phase 2 2004-07-01 A study of 3 doses of Progenta versus placebo versus Lucron Depot for treatment of leiomyomata.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION

Condition Name

Condition Name for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
Intervention Trials
Prostate Cancer 2
Uterine Leiomyomata 1
Breast Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
Intervention Trials
Prostatic Neoplasms 2
Myofibroma 1
Leiomyoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION

Trials by Country

Trials by Country for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
Location Trials
United States 42
Canada 9
Brazil 7
Japan 6
Italy 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
Location Trials
California 3
Ohio 3
Indiana 2
Florida 2
Arizona 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION

Clinical Trial Phase

Clinical Trial Phase for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
Clinical Trial Phase Trials
Phase 4 1
Phase 3 4
Phase 1/Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
Clinical Trial Phase Trials
Completed 4
Active, not recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION

Sponsor Name

Sponsor Name for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
Sponsor Trials
Tolmar Inc. 2
Myovant Sciences GmbH 1
Oakwood Laboratories, LLC 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
Sponsor Trials
Industry 5
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.